According to Bio-Rad Laboratories's latest financial reports the company's current EPS (TTM) is -$121.32. a decrease over its 2021 EPS that were of $142.64.
Year | EPS | Change |
---|---|---|
2022 | -$121.43 | -185.13% |
2021 | $142.64 | 11.5% |
2020 | $127.93 | 117.09% |
2019 | $58.93 | 383.83% |
2018 | $12.18 | 215.54% |
2017 | $3.86 | 302.08% |
2016 | $0.96 | -75.19% |
2015 | $3.87 | 25.65% |
2014 | $3.08 | 14.07% |
2013 | $2.70 | -54.85% |
2012 | $5.98 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $6.83 | -105.63% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | $17.76 | -114.64% | ๐บ๐ธ USA |
![]() Agilent Technologies A | $4.45 | -103.67% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $5.33 | -104.39% | ๐บ๐ธ USA |
![]() General Electric GE | -$0.41 | -99.66% | ๐บ๐ธ USA |
![]() Danaher DHR | $9.79 | -108.07% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $4.59 | -103.78% | ๐บ๐ธ USA |